1. Aceves M, Duenas A, Gomez C, San Vicente E, Crespo MS, Garcia-Rodriguez C (2004) A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription. Immunology 173: 5721–5729
2. Aflalo E, Seri I, Segal S, Gazit A, Priel E (1994) Inhibition of topoisomerase I activity tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action. Cancer 54: 5138–5142
3. Aranha O, Wood DP, Sarkar FH (2000) Ciprofloxacin mediated cell growth inhibition, S/G2-cell cycle, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Cancer Res 6: 891–900
4. Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood Jr DP, Sarkar FH (2003) Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Int J Oncol 22: 787–794
5. Bakshi RP, Galande S, Muniyappa K (2001) Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase. Crit Rev Biochem Mol Biol 36: 1–37